Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity.
To understand the balance of proteinase antiproteinase activity and the production of extracellular matrix (ECM) at the site of arterial injury, we analyzed the composition of ECM and proteinase activity in normal internal mammary arteries, tissue samples obtained from atherosclerotic coronary lesions and restenotic lesions obtained during directional coronary atherectomy. Histologically and biochemically, collagen and proteoglycans increased, and elastin decreased in samples from restenotic lesions when compared to samples taken from patients undergoing their first revascularization (de novo). In contrast, cellularity was increased in samples obtained from de novo patients as compared to samples obtained from restenotic lesions. Intrinsic activity of matrix metalloproteinases (MMPs) was measured by using zymography and scanning all the lytic bands in zymographic gel. In these gels, identical amounts of total protein were loaded in each lane. MMP activity was determined as % of the total (latent and active) MMPs after trypsin activation (100%) in the normal artery. Intrinsic MMP activity was reduced to 6% +/- 1% in atherosclerotic lesions and 1% +/- 1% in restenotic lesions, when compared to activity found in normal (10% +/- 3%) arteries. Based on solubilization of fluorescein-conjugated elastin by the extracts, the MMP-mediated elastinolytic activity was 0.2 +/- 0.1, 8.8 +/- 1.5, and 24.0 +/- 3 nmol/min/mg in restenotic, native atherosclerotic and normal tissue, respectively. The results suggested that, in arterial tissue from patients with angiographic restenosis, there is an increased production of ECM collagen and a decrease in MMP activity compared to both normal artery and atherosclerotic samples from de novo patients undergoing an initial revascularization procedure of a significant coronary artery lesion.
D000800:Angioplasty, Balloon; D001161:Arteriosclerosis / Q000201:enzymology* / Q000601:surgery; D017073:Atherectomy; D003094:Collagen / Q000378:metabolism; D004396:Coloring Agents; D003327:Coronary Disease / Q000201:enzymology* / Q000601:surgery; D003331:Coronary Vessels / Q000201:enzymology* / Q000648:ultrastructure; D004549:Elastin / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D007387:Internal Mammary-Coronary Artery Anastomosis; D008666:Metalloendopeptidases / Q000378:metabolism*; D008954:Models, Biological; D011509:Proteoglycans / Q000378:metabolism; D012008:Recurrence; D019714:Tissue Inhibitor of Metalloproteinases; D014945:Wound Healing
D004396:Coloring Agents; D016326:Extracellular Matrix Proteins; D006023:Glycoproteins; D011509:Proteoglycans; D019714:Tissue Inhibitor of Metalloproteinases; D003094:Collagen; D004549:Elastin; D008666:Metalloendopeptidases